279279© Springer-Verlag Berlin Heidelberg 2016C. Henze, Amerika, Land der unbegrenzten gendiagnostischen Möglichkeiten?, Veröffentlichungen des Instituts für Deutsches, Europäisches und Internationales Medizinrecht, Gesundheitsrecht und Bioethik der Universitäten Heidelberg und Mannheim, DOI 10.1007/978-3-662-48087-8

Verzeichnis der in der Arbeit genannten U.S.-amerikanischen Bundesgesetze

ADA Amendments Act of 2008 (ADAAA)Americans with Disabilities Act of 1990 (ADA)Clinical Laboratory Improvement Act of 1967Clinical Laboratory Improvement Amendments of 1988 (CLIA)Employee Retirement Income Security Act of 1974 (ERISA)Food and Drug Administration Modernization Act of 1997Food and Drug Administration Protection of Human Subjects RegulationsFood and Drug Administration Safety and Innovation Act (FDASIA)Food Drug and Cosmetic Act (FD&C Act)Family Medical Leave Act of 1993Federal Policy for the Protection of Human Subjects („Common Rule“)Federal Trade Commission Act of 1914 (FTC Act)Genetic Information Non-Discrimination Act of 2008 (GINA)Health Insurance Portability and Accountability Act of 1996 (HIPAA)HIPAA Omnibus Final RuleHIPAA Privacy RuleHIPAA Security RuleHuman Subject Protection Regulations of 1974Internal Revenue Code of 1986 (IRC)Medical Device Amendments of 1976Medical Device User Fee and Modernization Act of 2002Newborn Screening Saves Lives Act of 2007Patient Protection and Affordable Care Act (PPACA)Prescription Drug User Fee ActPublic Health Service Act of 1944 (PHSA)Safe Medical Devices Act of 1990 (SMDA)Social Security Act of 1935 (SSA)Uniform Deceptive Trade Practice Act of 1964 (UDTPA)

281

Literatur

23andMe Inc.: 23andMe Takes First Step Toward FDA Clearance – Pressemitteilung vom 30.07.2012, online verfügbar unter: http://mediacenter.23andme.com/press-releases/23andme-takes-first-step-toward-fda-clearance/ (letzter Zugriff: 01.06.2015).

Aaronson, Becca: Senate OKs Changes to Newborn Screening Program, The Texas Tribune vom 23.05.2011, online verfügbar unter: http://www.texastribune.org/2011/05/23/senate-oks-changes-to-newborn-screening-program/ (letzter Zugriff: 01.06.2015).

Ajunwa, Ifeoma: Genetic Data and Civil Rights (Veröffentlichung im Harvard Civil Rights-Ci-vil Liberties Law Review für 2015 angekündigt, vgl. die Angaben unter: http://www.law.udc.edu/?IAjunwa), Abstract vom 30.06.2014, online verfügbar unter: http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2460897 (letzter Zugriff: 01.06.2015).

Alexander, Duane/van Dyck, Peter C.: A Vision of the Future of Newborn Screening, Pediatrics Vol. 117 (Supplement 3) (2006), S 350–S 354.

Ameer, Barbara/Krivoy, Norberto: Direct-to-Consumer/Patient Advertising of Genetic Testing: A Position Statement of the American College of Clinical Pharmacology, The Journal of Clinical Pharmacology Vol. 49 (2009), 886–888.

American Academy of Pediatrics: Ethical and Policy Issues in Genetic Testing and Screening of Children, Pediatrics Vol. 131 (2013), 620–622.

American Clinical Laboratory Association: Citizen Petition against potential FDA regulation of Laboratory Developed Tests vom 04.06.2013, S. 1–19, online verfügbar unter: http://www.acla.com/wp-content/uploads/2013/12/060413-Citizen-Petition-to-FDA-Regarding-Laboratory-Developed-Tests-LDTs.pdf (letzter Zugriff: 01.06.2015) (zitiert: American Clinical Labora-tory Association, Citizen Petition vom 04.06.2013).

American College of Medical Genetics: Newborn Screening: Toward a Uniform Screening Panel and System, Genetics in Medicine Vol. 8 (2006), 1s–252s.

Dass.: ACMG Statement on Direct-to-Consumer Genetic Testing vom 11.04.2008, S. 1–2, online verfügbar unter: http://www.acmg.net/StaticContent/StaticPages/DTC_Statement.pdf (letzter Zugriff: 01.06.2015).

Dass.: Position Statement on Importance of Residual Newborn Screening Dried Blood Spots vom 29.04.2009, S. 1–2, online verfügbar unter: https://www.acmg.net/staticcontent/newsreleases/blood_spot_position_statement2009.pdf (letzter Zugriff: 01.06.2015).

American College of Medical Genetics and Genomics: NBSTRN Unveils New, First-of-its-Kind Virtual Repository For Newborn Screening Researchers: New System Will Save Lives and Improve Newborn Testing – Pressemitteilung vom 26.09.2012, S. 1–3, online verfügbar unter: https://www.acmg.net/docs/NBSTRN_Repository_News_Release.pdf (letzter Zugriff: 01.06.2015).

© Springer-Verlag Berlin Heidelberg 2016C. Henze, Amerika, Land der unbegrenzten gendiagnostischen Möglichkeiten?, Veröffentlichungen des Instituts für Deutsches, Europäisches und Internationales Medizinrecht, Gesundheitsrecht und Bioethik der Universitäten Heidelberg und Mannheim, DOI 10.1007/978-3-662-48087-8

282 Literatur

Dass.: Points to consider in the clinical application of genomic sequencing, Genetics in Medicine Vol. 14 (2012), 759–761.

Dass.: ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing, Genetics in Medicine Vol. 15 (2013), 565–574.

Dass.: Incidental findings in clinical genomics: a clarification, Genetics in Medicine Vol. 15 (2013a), 664–666.

Dass.: Points to consider for informed consent for genome/exome sequencing, Genetics in Medi-cine Vol. 15 (2013b), 748–749.

Dass.: Technical report: ethical and policy issues in genetic testing and screening of children, Genetics in Medicine Vol. 15 (2013c), 234–245.

Dass.: ACMG Updates Recommendation on “Opt Out” for Genome Sequencing Return of Re-sults – Pressemitteilung vom 01.04.2014, online verfügbar unter: https://www.acmg.net/docs/Release_ACMGUpdatesRecommendations_final.pdf (letzter Zugriff: 01.06.2015).

American College of Obstetricians and Gynecologists: ACOG Committee Opinion No. 360: Sex selection, Obstetrics & Gynecology Vol. 109 (2007), 475–478.

Dass.: Direct-to-Consumer Marketing of Genetic Testing – ACOG Committee Opinion No. 409, Obstetrics & Gynecology Vol. 111 (2008), 1493–1494.

Dass.: Update on Carrier Screening for Cystic Fibrosis, Committee Opinion No. 486, Obstetrics & Gynecology Vol. 117 (2011), 1028–1031.

American Health Lawyers Association Advisory Council on Racial and Ethnic Diversity: Patient-Tailored Medicine, Part One: The Impact of Race and Genetics on Medicine, Journal of Health & Life Sciences Law Vol. 2 (2008), 1–3, 5–36.

Dies.: Patient-Tailored Medicine, Part Two: Personalized Medicine and the Legal Landscape, Journal of Health & Life Sciences Law Vol. 2 (2009), 1–43.

American Medical Association: Brief von Michael D. Maves (Chief Executive Officer/AMA) an die FDA (Betreff: Molecular and Clinical Genetics Panel of Medical Devices Advisory Com-mittee Notice of Meeting) vom 23.02.2011, S. 1–3, online verfügbar unter: http://www.fda.gov/ucm/groups/fdagov-public/@fdagov-afda-adcom/documents/document/ucm248559.pdf (letzter Zugriff: 01.06.2015) (zitiert: Brief an die FDA vom 23.02.2011).

American Society for Clinical Pathology: Policy Statement – Regulation of Laboratory Developed Tests (LDTs), S. 1–8, online verfügbar unter: http://www.ascp.org/PDF/Advocacy/Regulation-of-laboratory-developed-tests-LDTs.aspx (letzter Zugriff: 01.06.2015).

American Society for Reproductive Medicine: Sex selection and preimplantation genetic diagnosis, Fertility and Sterility Vol. 82 (2004), 245–298.

American Society of Human Genetics: ASHG Statement – Professional Disclosure of Familial Genetic Information, American Journal of Human Genetics Vol. 62 (1998), 474–483.

Dies.: ASHG Statement on Direct-to-Consumer Genetic Testing in the United States, The Ameri-can Journal of Human Genetics Vol. 81 (2007), 635–637.

Dies./American College of Human Genetics: ASHG Report – Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents, American Jour-nal of Human Genetics Vol. 57 (1995), 1233–1241.

Anderson, Samuel W.: From the Cradle to the Lab, Gene Watch Vol. 24, No. 1 (2011), 12–17.Ashwood, Edward et al.: Brief von Edward Ashwood (President and CEO/ARUP Laboratories, Pro-

fessor of Pathology/University of Utah) und 23 Labordirektoren führender akademischer U.S.-Medizinlabore vom 17.07.2014 an Brian Deese (Acting Director, Office of Management and Budget/The White House), S. 1–6, online verfügbar unter: http://www.acla.com/wp-content/uploads/2014/07/Letter-to-OMB-from-Lab-Leaders.pdf (letzter Zugriff: 01.06.2015).

Aspinwall, Timothy J.: Imperfect Remedies: Legislative Efforts to Prevent Genetic Discrimination, Annals of Health Law Vol. 19 (2010), 121–125).

Association for Molecular Pathology: Revisiting Oversight and Regulation of Molecular-Based Laboratory-Developed Tests – A Position Statement of the Association for Molecular Pathol-ogy, The Journal of Molecular Diagnostics Vol. 16 (2014), 3–6.

Avery, Oswald T./MacLeod, Colin M./McCarty, Maclyn: Studies on the chemical nature of the substance inducing transformation of pneumococcal types. Induction of transformation by a

283Literatur

desoxiribonucleic acid fraction isolated from Pneumococcus Type III, The Journal of Experi-mental Medicine Vol. 79 (1944), 137–158.

Baruch, Susannah: Preimplantation Genetic Diagnosis and Parental Preferences: Beyond Deadly Desease, Houston Journal of Health Law & Policy Vol. 8 (2008), 245–270.

Dies./Hudson, Kathy: Civilian and Military Genetics: Nondiscrimination Policy in a Post-GINA World, The American Journal of Human Genetics Vol. 83 (2008), 435–444.

Dies./Kaufmann, David/Hudson, Kathy L.: Genetic testing of embryos: practices and perspectives of US in vitro fertilization clinics, Fertility and Sterility Vol. 89 (2008), 1053–1058.

Bauer, Andrea/Solinas-Toldo, Sabina/Hoheisel, Jörg D./Schirmacher, Peter/Penzel, Roland/Aretz, Stefan: Gendiagnostik – Methodische Grundlagen, in: Ganten, Detlev/Ruckpaul Klaus (Hrsg.), Grundlagen der Molekularen Medizin, 3. Auflage, Berlin, Heidelberg 2008, S. 347–362.

Beaudet, Arthur L.: Which way for genetic-test regulation? Leave test interpretation to specialists, Nature Vol. 466 (2010), 816–817.

Belton, Robert: Title VII at Forty: A Brief Look at the Birth, Death, and Resurrection of the Dis-parate Impact Theory of Discrimination, Hofstra Labor & Employment Law Journal Vol. 22 (2005), 431–472.

Berlin-Brandenburgische Akademie der Wissenschaften: Stellungnahme zu den neuen Sequenzie-rungstechniken und ihren Konsequenzen für die genetische Krankenversorgung, Berlin 2013 (zitiert: Berlin-Brandenburgische Akademie der Wissenschaften, Stellungnahme zu den neuen Sequenzierungstechniken (2013)).

Bloss, Cinnamon S./Schork, Nicholas J./Topol, Eric J.: Effect of Direct-to-Consumer Genomewide Profiling to Assess Disease Risk, The New England Journal of Medicine Vol. 364 (2011), 524–534.

Botkin, Jeffrey R.: Assessing the new criteria for newborn screening, Health Matrix Vol. 19 (2009), 163–186.

Brase, Twila: A Critical Analysis of the Implications for Genetic Privacy and Consent Rights in Congress’ Proposed “Newborn Screening Saves Lives Act of 2007”, Citizens’ Council on Health Care Report (March 2008), S. 1–8, online verfügbar unter: http://www.cchfreedom.org/pr/S_1858_NBS-DNAWarehouseFINAL.pdf (letzter Zugriff: 01.06.2015).

Dies.: Baby DNA Warehousing, Gene Watch Vol. 26 No. 1 (2014), 26–28.Brinkmann, Thomas: Die Zulässigkeit der Verwertung von genetischen Informationen im deut-

schen und amerikanischen Versicherungsrecht, Karlsruhe 2006 (zitiert: Brinkmann, Die Ver-wertung genetischer Informationen im Versicherungsrecht).

Brower, Vicki: FDA To Regulate Direct-to-Consumer Genetic Tests, Journal of the National Cancer Institute Vol. 102 (2010), 1610–1617.

Burgess, Lesley Jean/Pretorius, Deodanda: FDA abandons the Declaration of Helsinki: The effect on the ethical aspects of clinical trial conduct in South Africa and other developing countries, South African Journal of Bioethics and Law Vol. 5 (2012), 87–90.

Caggana, Michele/Jones, Elizabeth A./Shahied, S.I/Tanksley, Susan/Hermerath, Cheryl A./Lubin, Ira M.: Newborn Screening: From Guthrie to Whole Genome Sequencing, Public Health Re-ports Vol. 128 (2013), 14–19.

Campbell, Neil A.: Biologie, 8. Auflage, München, Boston 2009.Carnahan, Sandra J.: Biobanking Newborn Bloodspots for Genetic Research Without Consent,

Journal of Health Care Law and Policy Vol. 14 (2011), 299–330.Caulfield, Timothy: Direct-to-consumer testing: if consumers are not anxious, why are policymak-

ers?, Human Genetics Vol. 130 (2011), 23–25.Centers for Disease Control and Prevention: Genetic Testing for Breast and Ovarian Cancer Sus-

ceptibility: Evaluating Direct-to-Consumer Marketing – Atlanta, Denver, Raleigh-Durham, and Seattle, 2003, Morbidity and Mortality Weekly Report Vol. 53 (2004), 603–606, online verfüg-bar unter: http://www.cdc.gov/mmwr/PDF/wk/mm5327.pdf (letzter Zugriff: 01.06.2015).

Dies.: Good Laboratory Practices for Molecular Genetic Testing for Heritable Diseases and Con-ditions, Morbidity and Mortality Weekly Report Vol. 58 (2009), 1–37, online verfügbar unter: http://www.cdc.gov/mmwr/PDF/rr/rr5806.pdf (letzter Zugriff: 01.06.2015).

284 Literatur

Dies.: Newborn Screening Contingency Plan (July 2010), S. 1–44, online verfügbar unter: http://www.cdc.gov/ncbddd/documents/NBS-CONPLAN.pdf (letzter Zugriff: 01.06.2015).

Dies.: Good Laboratory Practices for Biochemical Genetic Testing and Newborn Screening for Inherited Metabolic Disorders, Morbidity and Mortality Weekly Report Vol. 61 (2012), S. 1–44, online verfügbar unter: http://www.cdc.gov/mmwr/pdf/rr/rr6102.pdf (letzter Zugriff: 01.06.2015).

Centers for Medicare and Medicaid Services: Brief von Dennis G. Smith (Director, Center for Medicaid and State Operations/CMS) vom 15.08.2007 an Kathy Hudson (Director, Genetics and Public Policy Center/Johns Hopkins University), S. 1–15, online verfügbar unter: http://www.bioethicsinstitute.org/wp-content/uploads/2012/10/CMSresponse8.15.pdf (letzter Zu-griff: 01.06.2015) (zitiert: Centers for Medicare and Medicaid Services, Brief vom 15.08.2007 an Kathy Hudson (Director, Genetics and Public Policy Center/Johns Hopkins University)).

Dies.: Appendix C – Procedures and Interpretive Guidelines for Laboratories and Laboratory Services, S. 1–413, online verfügbar unter: http://www.cms.gov/Regulations-and-Guidance/Legislation/CLIA/Interpretive_Guidelines_for_Laboratories.html (letzter Zugriff: 01.06.2015).

Dies.: Direct Access Testing (DAT) and the Clinical Laboratory Improvement Amendments (CLIA) Regulations, online verfügbar unter: http://www.cms.gov/Regulations-and-Guidance/Legislation/CLIA/downloads/directaccesstesting.pdf (letzter Zugriff: 01.06.2015)

Dies.: List of Approved Accrediting Organizations under the Clinical Laboratory Improve-ment Amendments (CLIA), S. 1, online verfügbar unter: http://www.cms.gov/Regulations-and-Guidance/Legislation/CLIA/Downloads/AOList.pdf (letzter Zugriff: 01.06.2015).

Dies.: CLIA Approved Proficiency Testing Programs (Stand: 2014), S. 1–40, online verfügbar unter: http://www.cms.gov/Regulations-and-Guidance/Legislation/CLIA/Downloads/ptlist.pdf (letzter Zugriff: 01.06.2015).

Check Hayden, Erika: Fetal gene screening comes to market, Nature Vol. 478 (2011), 440.Dies.: Nanopore genome sequencer makes its debut, Nature News vom 17.02.2012, online verfüg-

bar unter: http://www.nature.com/news/nanopore-genome-sequencer-makes-its-debut-1.10051 (letzter Zugriff: 01.06.2015).

Dies.: Is the $1.000 genome for real?, Nature News vom 15.01.2014, online verfügbar unter: http://www.nature.com/news/is-the-1-000-genome-for-real-1.14530 (letzter Zugriff: 01.06.2015).

Clinical Laboratory Standards Institute: Assessment of Laboratory Tests When Proficiency Test-ing Is Not Available, Approved Guideline – Second Edition (Stand: August 2008), CLSI docu-ment GP29-A2, 2. Auflage, Wayne, Pennsylvania 2008.

Dass.: Quality Management System: A Model for Laboratory Services, Approved Guideline – Fourth Edition (Stand: Juni 2011), CLSI document QMS01-A4, 4. Auflage, Wayne, Pennsyl-vania 2011 (zitiert: Clinical Laboratory Standards Institute, Quality Management System: A Model for Laboratory Services).

Cohen, Stanley N./Chang, Annie C. Y./Boyer, Herbert W./Helling, Robert B.: Construction of Biologically Functional Bacterial Plasmids In Vitro, Proceedings of the National Academy of Sciences U.S.A. Vol. 70 (1973), 3240–3244.

Cole, Laura J./Fleisher, Lynn D.: Update on HIPAA privacy: Are you ready?, Genetics in Medi-cine Vol. 5 (2003), 183–186.

Collins, Francis S.: The Language of God, New York 2006.Ders.: Has the revolution arrived?, Nature Vol. 464 (2010), 674–675.Council for Responsible Genetics: FDA Investigation into Direct to Consumer Genetic Testing

Companies (2010), S. 1–4, online verfügbar unter: http://www.councilforresponsiblegenetics.org/pagedocuments/ukaa8jrbxq.pdf (letzter Zugriff: 01.06.2015).

Ders.: Newborn Screening In America: Problems and Policies (2012), S. 1–43, online verfüg-bar unter: http://www.councilforresponsiblegenetics.org/pageDocuments/WNMAKEPP1P.pdf (letzter Zugriff: 01.06.2015).

Crockin, Susan L.: Reproduction, genetics and the law, Reproductive BioMedicine Online Vol. 10 (2005), 692–704.

DeNavas-Walt, Carmen/Proctor, Bernadette D./Smith, Jessica C.: Income, Poverty, and Health Insurance Coverage in the United States: 2012, U.S. Census Bureau Current Population Re-port P 60-245 (September 2013), S. i-77, online verfügbar unter: http://www.census.gov/prod/

285Literatur

2013pubs/p60-245.pdf (letzter Zugriff: 01.06.2015) (zitiert: DeNavas-Walt/Proctor/Smith, U.S. Census Bureau Current Population Report (September 2013)).

Department of Health and Human Services: Guidance on Research Involving Coded Private Infor-mation or Biological Specimens (Stand: 16.10.2008), online verfügbar unter: http://www.hhs.gov/ohrp/policy/cdebiol.html (letzter Zugriff: 01.06.2015).

Dass.: Summary from the Molecular & Clinical Genetics Panel Meeting (08./09.03.2011), S. 1–5, online verfügbar unter: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/MolecularandClinicalGeneticsPanel/UCM246907.pdf (letzter Zugriff: 01.06.2015).

Dass.: Health Information Privacy: Research (Stand: Juni 2013), online verfügbar unter: http://www.hhs.gov/ocr/privacy/hipaa/understanding/special/research/ (Letzter Zugriff: 01.06.2015).

Dettmeyer, Reinhard: Medizin und Recht: Rechtliche Sicherheit für den Arzt, 2. Auflage, Heidel-berg 2006.

Deutsch, Erwin/Taupitz, Jochen: Deklaration von Helsinki des Weltärztebundes, in: Winter, Stefan F./Fenger, Hermann/Schreiber, Hans-Ludwig (Hrsg.), Genmedizin und Recht. Rahmenbedin-gungen und Regelungen für Forschung, Entwicklung, Klinik, Verwaltung, München 2001, Rn. 527–544.

Deutsche Akademie der Naturforscher Leopoldina – Nationale Akademie der Wissenschaften/aca-tech – Deutsche Akademie der Technikwissenschaft/Berlin-Brandenburgische Akademie der Wissenschaften: Prädiktive genetische Diagnostik als Instrument der Krankheitsprävention – Stellungnahme (November 2010), S. I–90, online verfügbar unter: http://www.leopoldina.org/uploads/tx_leopublication/201011_natEmpf_praedikative-DE.pdf (letzter Zugriff: 01.06.2015) (zitiert: Deutsche Akademie der Naturforscher Leopoldina et al., Stellungnahme Prädiktive Genetische Diagnostik (November 2010)).

Deutscher Ethikrat: Die Zukunft der genetischen Diagnostik – von der Forschung in die klini-sche Anwendung, Stellungnahme vom 30.04.2013, S. 1–209, online verfügbar unter: http://www.ethikrat.org/dateien/pdf/stellungnahme-zukunft-der-genetischen-diagnostik.pdf (letzter Zugriff: 01.06.2015) (zitiert: Deutscher Ethikrat, Stellungnahme zur Zukunft der genetischen Diagnostik (April 2013)).

Discretionary Advisory Committee on Heritable Disorders in Newborns and Children: Recom-mended Uniform Screening Panel (Stand: April 2013), S. 1–2, online verfügbar unter: http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders/recommendedpanel/ uniformscreeningpanel.pdf (letzter Zugriff: 01.06.2015).

Dole Jr., Richard F.: Merchant and Consumer Protection: The Uniform Deceptive Trade Practices Act, Yale Law Journal Vol. 76 (1967), 485–506.

Duncan, Helena: An Update on the Clinical Laboratory Improvement Amendments of 1988, La-boratory Medicine Vol. 39 (2008), 69–72.

Ehrich, Mathias/Deciu, Cosmin/Zwiefelhofer, Tricia et al.: Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting, American Journal of Obstetrics & Gynecology Vol. 204 (2011), 205.e1–205.e11.

Emerson, Thomas I.: Toward a General Theory of the First Amendment, Yale Law Journal Vol. 72 (1963), 877–956.

Emmert, Frank/Fine, Toni M.: Einführung in das Amerikanische Rechts(system), in: Bugg, Stuart G./Simon, Heike (Hrsg.), Fachwörterbuch Kompakt Recht -Englisch, 2. Auflage, Berlin, Mün-chen 2009, S. 76–105.

Equal Employment Opportunity Commission: EEOC and BNSF settle Genetic Testing Case under Americans with Disabilities Act – Pressemitteilung vom 08.05.2002, online verfügbar unter: http://www.eeoc.gov/eeoc/newsroom/release/5-8-02.cfm (letzter Zugriff: 01.06.2015).

European Society of Human Reproduction and Embryology: ESHRE PGD Consortium/Embryol-ogy Special Interest Group – best practice guidelines for polar body and embryo biopsy for preimplantation genetic diagnosis/screening (PGD/PGS), Human Reproduction Vol. 26 (2011), 41–46.

Dies.: ESHRE PGD Consortium best practice guidelines for organization of a PGD centre for PGD/preimplantation genetic screening, Human Reproduction Vol. 27 (2012), 14–24.

286 Literatur

Evans, D. Gareth R./Barwell, Julian/Eccles, Diana M./Collins, Amanda/Izatt, Louise/Jacobs, Chris/Donaldson, Alan/Brady, Angelina F./Cuthbert, Andrew/Harrison, Rachel/Thomas, Sue/Howell, Anthony/Miedzybrodzka, Zosia/Murray, Alex: The Angelina Jolie effect: how high ce-lebrity profile can have a major impact on provision of cancer related services, Breast Cancer Research Vol. 16 (2014), 442–447.

Federal Trade Commission: FTC Policy Statement on Unfairness vom 17.12.1980, online verfüg-bar unter: http://www.ftc.gov/bcp/policystmt/ad-unfair.htm (letzter Zugriff: 01.06.2015).

Dies.: FTC Policy Statement Regarding Advertising Substantiation vom 11.03.1983, online ver-fügbar unter: http://www.ftc.gov//bcp/guides/ad3subst.htm (letzter Zugriff: 01.06.2015).

Dies.: FTC Policy Statement on Deception vom 14.10.1983, online verfügbar unter: http://www.ftc.gov/bcp/policystmt/ad-decept.htm (letzter Zugriff: 01.06.2015).

Dies.: “Operation Cure.All” Wages New Battle in Ongoing War Against Internet Health Fraud – Pressemitteilung vom 14.06.2001, online verfügbar unter: http://www.ftc.gov/news-events/press-releases/2001/06/operation-cureall-wages-new-battle-ongoing-war-against-internet (letzter Zugriff: 01.06.2015).

Dies.: Consumer Information, At-Home Genetic Tests: Health Information for Older People (Stand: Oktober 2008), online verfügbar unter: http://www.consumer.ftc.gov/articles/0325-home-genetic-tests-health-information-older-people (letzter Zugriff: 01.06.2015).

Dies.: Consumer Information, Direct-to-Consumer Genetic Tests (Stand: Januar 2014), online ver-fügbar unter: http://www.consumer.ftc.gov/articles/0166-home-genetic-tests (letzter Zugriff: 01.06.2015).

Dies.: FTC Approves Final Consent Orders Settling Charges that Companies Deceptively Claimed Their Genetically Modified Nutritional Supplements Could Treat Diseases – Pres-semitteilung vom 12.05.2014, online verfügbar unter: http://www.ftc.gov/news-events/press-releases/2014/05/ftc-approves-final-consent-orders-settling-charges-companies (letzter Zugriff: 01.06.2015).

Fine Maron, Dina: US doctors’ group says patients should have option not to know their DNA, Nature News vom 1. April 2014, online verfügbar unter: http://www.nature.com/news/us-doctors-group-says-patients-should-have-option-not-to-know-their-dna-1.14976 (letzter Zugriff: 01.06.2015).

Fulda, Gerhard F.: UNESCO-Deklaration über das menschliche Genom und Menschenrechte, in: Winter, Stefan F./Fenger, Hermann/Schreiber, Hans-Ludwig (Hrsg.), Genmedizin und Recht. Rahmenbedingungen und Regelungen für Forschung, Entwicklung, Klinik, Verwaltung, Mün-chen 2001, Rn. 500–522.

Food and Drug Administration: Memorandum of Understanding No. 225-71-8003, Updated Liai-son Agreement: Advertising of Over the Counter Drugs (1971), online verfügbar unter: http://www.fda.gov/AboutFDA/PartnershipsCollaborations/MemorandaofUnderstandingMOUs/DomesticMOUs/ucm115791.htm (letzter Zugriff: 01.06.2015) (zitiert: Food and Drug Admin-istration, Memorandum of Understanding No. 225-71-8003 (1971)).

Dies.: Zusage über die Umklassifizierung des Factor V Leiden Kit vom 17.12.2003, S. 1–3, online verfügbar unter: http://www.accessdata.fda.gov/cdrh_docs/pdf3/K033607.pdf (letzter Zugriff: 01.06.2015).

Dies.: Zusage über die Umklassifizierung des Roche AmpliChip CYP450 vom 23.12.2004, S. 1–3, online verfügbar unter: http://www.accessdata.fda.gov/cdrh_docs/pdf4/K042259.pdf (letzter Zugriff: 01.06.2015).

Dies.: Zusage über die Umklassifizierung des Tag-It Cystic Fibrosis Kit vom 09.05.2005, S. 1–3, online verfügbar unter: http://www.accessdata.fda.gov/cdrh_docs/pdf4/K043011.pdf (letzter Zugriff: 01.06.2015).

Dies.: FDA Approves First Molecular-Based Lab Test to Detect Metastatic Breast Cancer – Pressemitteilung vom 16.07.2007, online verfügbar unter: http://www.fda.gov/newsevents/newsroom/pressannouncements/2007/ucm108949.htm (letzter Zugriff: 01.06.2015).

Dies.: Draft Guidance for Industry, Clinical Laboratories, and FDA Staff vom 26.07.2007– In Vitro Diagnostic Multivariate Index Assays, S. 1–15, online verfügbar unter: http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm071455.pdf (letzter Zugriff: 01.06.2015) (zitiert: Food and Drug Administration, Draft Guidance vom 26.07.2007 – In Vitro Diagnostic Multivariate Index Assays).

287Literatur

Dies.: FDA Approves Updated Warfarin (Coumadin) Prescribing Information – Pressemittei-lung vom 16.08.2007, online verfügbar unter: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108967.htm (letzter Zugriff: 01.06.2015).

Dies.: Guidance for Industry: Regulation of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) (Stand: August 2007), S. i–13, online verfügbar unter: http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Tissue/ucm062592.pdf (letzter Zugriff: 01.06.2015).

Dies.: Guidance for Industry and FDA Staff vom 14.09.2007 – Commercially Distributed Analyte Specific Reagents (ASRs), S. 1–13, online verfügbar unter: http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm071269.pdf (letz-ter Zugriff: 01.06.2015) (zitiert: Food and Drug Administration, Guidance vom 14.09.2007 – Commercially Distributed ASRs).

Dies.: FDA Approves New Genetic Test for Breast Cancer Patients – Pressemitteilung vom 14.01.2008, online verfügbar unter: http://www.fda.gov/newsevents/newsroom/pressannouncements/2008/ucm116834.htm (letzter Zugriff: 01.06.2015).

Dies.: Guidance for Industry and FDA Staff vom 30.01.2008 – Recommendations for Clinical La-boratory Improvement Amendments of 1988 (CLIA) Waiver Applications for Manufacturers of In Vitro Diagnostic Devices, S. 1–45, online verfügbar unter: http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm070890.pdf (letzter Zugriff: 01.06.2015) (zitiert: Food and Drug Administration, Guidance vom 30.01.2008 – Re-commendations for CLIA Waiver Applications for Manufacturers of IVDs).

Dies.: FDA Clears Test that Helps Identify Type of Cancer in Tumor Sample – Pressemittei-lung vom 31.07.2008, online verfügbar unter: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2008/ucm116931.htm (letzter Zugriff: 01.06.2015).

Dies.: Brief an David P. King (President and CEO/Laboratory Corporation of America) vom 07.08.2008, online verfügbar unter: http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/IVDRegulatoryAssistance/ucm125130.htm (letzter Zugriff: 01.06.2015).

Dies.: FDA Oversight of Direct-to-Consumer Advertising of Medical Devices, Statement of Daniel Schultz (Director, Center for Devices and Radiological Health/FDA) before the U.S. Senate Special Committee on Aging am 17.09.2008, online verfügbar unter: http://www.fda.gov/NewsEvents/Testimony/ucm096272.htm (letzter Zugriff: 01.06.2015).

Dies.: FDA Clears a Test for Ovarian Cancer, Pressemitteilung vom 11.09.2009, online verfüg-bar unter: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm182057.htm (letzter Zugriff: 01.06.2015).

Dies.: Public Meeting on Oversight of Laboratory Developed Tests (19./20.07.2010) – Pro-tokoll vom 19.07.2010, S. 1–237, online verfügbar unter: http://www.fda.gov/downloads/MedicalDevices/NewsEvents/WorkshopsConferences/UCM226203.pdf (letzter Zugriff: 01.06.2015).

Dies.: Fact Sheet: Medical Device User Fee Amendments of 2012, online verfügbar unter: http://www.fda.gov/RegulatoryInformation/Legislation/SignificantAmendmentstotheFDCAct/FDASIA/ucm313695.htm (letzter Zugriff: 01.06.2015).

Dies.: Approval Letter – „PROGENSA PCA3 Assay“ vom 13.02.2012, S. 1–4, online verfüg-bar unter: http://www.accessdata.fda.gov/cdrh_docs/pdf10/p100033a.pdf (letzter Zugriff: 01.06.2015).

Dies.: Commissioner ’s Address, Annual Meeting of the American Society of Clinical Oncology (02.06.2013), online verfügbar unter: http://www.fda.gov//NewsEvents/Speeches/ucm354888.htm (letzter Zugriff: 01.06.2015).

Dies.: Warning Letter 23andMe vom 22.11.2013, online verfügbar unter: http://www.fda.gov/iceci/enforcementactions/warningletters/2013/ucm376296.htm (letzter Zugriff: 01.06.2015).

Dies.: Guidance for Industry and Food and Drug Administration Staff vom 28.07.2014 – The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)], S. 1–39, online verfügbar unter: http://www.fda.gov/downloads/MedicalDevices/…/UCM284443.pdf (letzter Zugriff: 01.06.2015) (zitiert: Food and Drug Administration, Guid-ance vom 28.07.2014 – The 510(k) Program).

Dies.: Draft Guidance for Industry, Food and Drug Administration Staff, and Clinical Laboratories vom 03.10.2014 – Framework for Regulatory Oversight of Laboratory Developed Tests

288 Literatur

(LDTs), S. 1–41, online verfügbar unter: http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM416685.pdf (letzter Zugriff: 01.06.2015) (zitiert: Food and Drug Administration, Draft Guidance vom 03.10.2014 – Frame-work for Regulatory Oversight of LDTs).

Dies.: Draft Guidance for Industry, Food and Drug Administration Staff, and Clinical Labora-tories vom 03.10.2014 – FDA Notification and Medical Device Reporting for Laboratory Developed Tests (LDTs), S. 1–28, online verfügbar unter: http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM416684.pdf (letzter Zugriff: 01.06.2015) (zitiert: Food and Drug Administration, Draft Guidance vom 03.10.2014 – FDA Notification and Medical Device Reporting for LDTs).

Dies.: Stellungnahme vom 31.07.2014 zur Petition des Biotechnologie-Unternehmens „Ge-nentech“ vom 05.12.2008, S. 1–8, online verfügbar unter: https://docs.google.com/file/d/0ByfvmAdtUMANbXhRYkthVGxTdlk/edit?pli=1 (letzter Zugriff: 01.06.2015).

Dies.: Guidance for Industry and FDA Staff vom 06.08.2014 – In Vitro Companion Diagnostic Devices, S. 1–13, online verfügbar unter: http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM262327.pdf (letzter Zugriff: 01.06.2015) (zitiert: Food and Drug Administration, Guidance vom 06.08.2014 – In Vitro Companion Diagnostic Devices).

Dies.: Draft Guidance for Industry and Food and Drug Administration Staff vom 14.08.2014 – De Novo Classification Process (Evaluation of Automatic Class III Designation), S. 1–16, online ver-fügbar unter: http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM273903.pdf (letzter Zugriff: 01.06.2015) (zitiert: Food and Drug Administration, Draft Guidance vom 14.08.2014 – De Novo Classification Process).

Dies.: Fact Sheet: Reauthorization of User Fees for Prescription Drugs Will Ensure a Predictable and Efficient Human Drug Review Program vom 09.07.2012, online verfügbar unter: http://www.fda.gov/RegulatoryInformation/Legislation/SignificantAmendmentstotheFDCAct/FDASIA/ucm311238.htm (letzter Zugriff: 01.06.2015).

Dies.: Guidance for Industry: Consumer Directed Broadcast Advertisements (Stand: August 1999), S. 1–4, online verfügbar unter: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070065.pdf (letzter Zugriff: 01.06.2015).

Ford, Paul Leicester: The Works of Thomas Jefferson in Twelve Volumes, Correspondence and Official Papers 1816–1826 (Vol. 12), New York, London 1905 (zitiert: Ford, The Works of Thomas Jefferson (Vol. XII)).

Friedman, Gerald/Reichelt, Richard: ELSI: Ethical, Legal, and Social Implications of the Human Genome Project, Los Alamos Science Vol. 20 (1992), 302–313.

Fukuyama, Francis: Our posthuman future. Consequences of the biotechnological revolution, New York 2002.

Ders./Furger, Franco: Beyond Bioethics: A Proposal for Modernizing the Regulation of Human Biotechnologies (2006), S. 1–355, online verfügbar unter: http://ieet.org/archive/Fukuyama-BiotechReg2006.pdf (letzter Zugriff: 01.06.2015).

Garvey, Todd/Chu, Vivian S.: Executive Orders: Issuance, Modification, and Revocation (16.04.2014), S. 1–10, online verfügbar unter: http://www.fas.org/sgp/crs/misc/RS20846.pdf (letzter Zugriff: 01.06.2015).

Geetter, Jennifer S.: Coding for change: the power of the human genome to transform the Ameri-can Health Insurance System, American Journal of Law & Medicine Vol. 28 (2002), 1–76.

Genentech: Citizen Petition to FDA vom 05.12.2008– Regulation of In Vitro Diagnostic Tests, S. 1–31, online verfügbar unter: http://www.aab.org/images/aab/pdf/Genentch%20FDA%20Petition.pdf (letzter Zugriff: 01.06.2015) (zitiert: Genentech, Citizen Petition to FDA vom 05.12.2008).

Genetics and Public Policy Center: Public Awareness and Attitudes about Reproductive Genet-ic Technology (2002), S. 1–31, online verfügbar unter: https://jscholarship.library.jhu.edu/bitstream/handle/1774.2/979/PublicAwarenessAndAttitudes.pdf?sequence=1 (letzter Zugriff: 01.06.2015).

Dass.: Preimplantation Genetic Diagnosis. A Discussion of Challenges, Concerns, and Prelimi-nary Policy Options Related to the Genetic Testing of Human Embryos (2004a), S. 1–30,

289Literatur

online verfügbar unter: https://jscholarship.library.jhu.edu/bitstream/handle/1774.2/978/PGDDiscussionChallengesConcerns.pdf?sequence=1 (letzter Zugriff: 01.06.2015) (zitiert: Genetics and Public Policy Center, Preimplantation Genetic Diagnosis (2004a)).

Dass.: Reproductive Genetic Testing: What America Thinks (2004b), S. 1–66, online verfügbar unter: https://jscholarship.library.jhu.edu/bitstream/handle/1774.2/976/ReproGenTestAmericaThinks.pdf?sequence=1 (letzter Zugriff: 01.06.2015).

Dass.: Reproductive Genetic Testing: Issues and Options for Policymakers (2004c), S. 1–61, online verfügbar unter: https://jscholarship.library.jhu.edu/bitstream/handle/1774.2/977/ReproGenTestIssuesOptions.pdf?sequence=1 (letzter Zugriff: 01.06.2015).

Dass.: Petition for Rulemaking vom 26.09.2006, online verfügbar unter: http://www.citizen.org/Page.aspx?pid=622 (letzter Zugriff: 01.06.2015).

Dass.: U.S. Public Opinion on Uses of Genetic Information and Genetic Discrimination (April 2007), S. 1–4, online verfügbar unter: http://research.policyarchive.org/10939.pdf (letzter Zu-griff: 01.06.2015).

Dass.: Survey of Direct-to-Consumer Testing Statutes and Regulations (Stand: Juni 2007), S. 1–15, online verfügbar unter: http://web.archive.org/web/20071005020300/http://www.dnapolicy.org/resources/DTCStateLawChart.pdf (letzter Zugriff: 01.06.2015).

Dass.: Updated List of DTC Genetic Testing Companies (Stand: August 2011), S. 1–15, online verfügbar unter: http://web.archive.org/web/20130612084919/http://www.dnapolicy.org/resources/DTCTableAug2011Alphabydisease.pdf (letzter Zugriff: 01.06.2015).

Gibbs, W. Wayt: The Unseen Genome: Gems among the Junk, Scientific American Vol. 289 (2003), 46–53.

Gniady, Jennifer A.: Regulating Direct-to-Consumer Genetic Testing: Protecting the Consumer Without Quashing a Medical Revolution, Fordham Law Review Vol. 76 (2008), 2429–2475.

Gollust, Sarah E/Hull, Sarah C./Wilfond, Benjamin S.: Limitations of Direct-to-Consumer Ad-vertising for Clinical Genetic Testing, Journal of the American Medical Association Vol. 288 (2002), 1762–1767.

Dies.: Direct-to-consumer sales of genetic services on the Internet, Genetics in Medicine Vol. 5 (2003), 332–337.

Gostin, Lawrence O.: Public Health Law. Power, Duty, Restraint, 2. Auflage, Berkeley/Kalifornien 2008 (zitiert: Gostin, Public Health Law).

Greely, Henry T./Riordan, Daniel P./Garrison, Nanibaa’ A./Mountain, Joanna L.: Family Ties: The Use of DNA Offender Databases to Catch Offenders’ Kin, The Journal of Law, Medicine & Ethics Vol. 34 (2006), 248–262.

Ders.: Get ready for the flood of fetal gene screening, Nature Vol. 469 (2011), 289–291.Green, Eric D./Guyer, Mark S./Manolio, Teri A./Peterson, Jane L.: Charting a course for genomic

medicine from base pairs to bedside, Nature Vol. 470 (2011), 204–213.Green, Nancy S./Pass, Kenneth A.: Neonatal screening by DNA microarray: spots and chips, Na-

ture Reviews Genetics Vol. 6 (2005), 147–151.Grosse, S.D/Rogowski, W.H/Ross, L.F/Cornel, M.C/Dondorp, W.J/Khoury, M.J.: Population

Screening for Genetic Disorders in the 21st Century: Evidence, Economics, and Ethics, Public Health Genomics Vol. 13 (2010), 106–115.

Gruber, Jeremy: GINA: How It Came to Pass and What It Does, Gene Watch Vol. 22 No. 2 (2009), 4–6, 14.

Ders.: DTC Genetic Testing: Consumer Privacy Concerns, Gene Watch Vol. 23 No. 4 (2010), 18–19.

Gutjahr, Richard: Sie haben ein erhöhtes Risiko für Prostatakrebs, F.A.Z. vom 07.11.2013, S. 27.Gutman, Steven: Update from FDA – FDA’s Proposed Review Template for Genetic Tests: Ad-

ditional Test Examples and Potential Outcomes of Review, Secretary’s Advisory Committee on Genetic Testing, Ninth Meeting (02. Mai 2001), S. 15–28, online verfügbar unter: http://osp.od.nih.gov/sites/default/files/SACGT5-2r.AM_.pdf (letzter Zugriff: 01.06.2015) (zitiert: Gutman, FDA’s Proposed Review Template for Genetic Tests).

Halberstam, David: Defining America. Führende amerikanische Intellektuelle erklären den Cha-rakter ihrer Nation, Hamburg 2004.

290 Literatur

Hamilton, Thomas: At Home DNA Tests: Marketing Scam Or Medical Breakthrough? – Tes-timony on CLIA and Genetic Testing in: Hearing before the Special Committee on Aging, U.S.-Senate, 109th Congress am 27.07.2006, S. 107–121, online verfügbar unter: http://www.aging.senate.gov/imo/media/doc/7272006.pdf (letzter Zugriff: 01.06.2015) (zitiert: Hamilton, At Home DNA Tests: Marketing Scam Or Medical Breakthrough? – U.S.-Senate Hearing vom 27.07.2006).

Ders./Yost, Judith: Developments at CMS, Secretary’s Advisory Committee on Genetics, Health, and Society Meeting (13./14.11.2006), Sitzungsprotokoll, S. 1–8, online verfügbar unter: http://osp.od.nih.gov/sites/default/files/Genetic_Tech-Hamilton-Yost.pdf (letzter Zugriff: 01.06.2015).

Hay, Peter: US-Amerikanisches Recht, 5. Auflage, München, Wien 2011.Hecht, Alexander N.: The Wild Wild West: Inadequate Regulation of Assisted Reproductive Tech-

nology, Houston Journal of Health Law & Policy Vol. 1 (2001), 227–261.Hogarth, Stuart/Javitt, Gail/Melzer, David: The Current Landscape for Direct-to-Consumer

Genetic Testing: Legal, Ethical, and Policy Issues, Annual Review of Genomics and Human Genetics Vol. 9 (2008), 161–182.

Holtzman, Neil A.: Promoting Safe and Effective Genetic Tests in the United States: Work of the Task Force on Genetic Testing, Clinical Chemistry Vol. 45 (1999), 732–738.

Hudson, Kathy L.: Preimplantation genetic diagnosis: public policy and public attitudes, Fertility and Sterility Vol. 85 (2006), 1638–1645.

Dies.: At Home DNA Tests: Marketing Scam Or Medical Breakthrough?, Hearing before the Special Committee on Aging, U.S.-Senate, 109th Congress (July 27th 2006) – Testimony, S. 30–46, online verfügbar unter: http://www.aging.senate.gov/imo/media/doc/7272006.pdf (letzter Zugriff: 01.06.2015) (zitiert: Hudson, At Home DNA Tests: Marketing Scam Or Medi-cal Breakthrough? – U.S.-Senate Hearing vom 27.07.2006).

Dies.: Prohibiting Genetic Discrimination, The New England Journal of Medicine Vol. 356 (2007), 2021–2023.

Dies.: Genomics, Health Care, and Society, The New England Journal of Medicine Vol. 365 (2011), 1033–1041.

Dies./Baruch, Susannah/Javitt, Gail H.: Genetic Testing of Human Embryos: Ethical Challeng-es and Policy Choices (2005), S. 1–32, online verfügbar unter: https://repository.library.georgetown.edu/handle/10822/506242 (letzter Zugriff: 01.06.2015).

Dies./Holohan M.K/Collins Francis S.: Keeping Pace with the Times – The Genetic Informa-tion Nondiscrimination Act of 2008, The New England Journal of Medicine Vol. 358 (2008), 2661–2663.

Dies./Murphy, Juli A./Kaufman, David J./Javitt, Gail H./Katsanis, Sara H./Scott, Joan: Oversight of U.S. genetic testing laboratories, Nature Biotechnology Vol. 24 (2006), 1083–1090.

Hull, Sara Chandros/Prasad, Kiran: Reading between the Lines: Direct-to-Consumer Advertising of Genetic Testing, The Hastings Center Report Vol. 31 (2001), 33–35.

Human Genetics Commission: Genes direct – Ensuring the effective oversight of genetic tests sup-plied directly to the public (Report 2003), S. 1–48, online verfügbar unter: http://webarchive. nationalarchives.gov.uk/20070205104008/http://hgc.gov.uk/UploadDocs/Contents/Documents/Genes%20direct%20-%20FULL%20REPORT%20FINAL.pdf (letzter Zugriff: 01.06.2015) (zitiert: Human Genetics Commission, Genes direct (Report 2003)).

International Human Genome Sequencing Consortium: Initial sequencing and analysis of the hu-man genome, Nature Vol. 409 (2001), 860–921.

Dass.: Finishing the euchromatic sequence of the human genome, Nature Vol. 431 (2004), 931–945.

Inthorn Julia/Wehling, Peter/Schultz, Susanne/Schicktanz, Silke: Diagnostik mit Fragezeichen, Deutsches Ärzteblatt Vol. 111 (2014), A 345–A 346.

Jackson, David A./Symons, Robert H./Berg, Paul: Biochemical Method for Inserting New Genetic Information into DNA of Simian Virus 40: Circular SV40 DNA Molecules Containing Lambda Phage Genes and the Galactose Operon of Escherichia coli, Proceedings of the National Acad-emy of Sciences U.S.A. Vol. 69 (1972), 2904–2909.

291Literatur

Javaher, Poupak/Schmidtke, Jörg, Die Bewertung genetischer Tests im klinischen Kontext, in: Schmidtke, Jörg/Müller-Röber, Bernd/van den Daele, Wolfgang/Hucho, Ferdinand/ Köchy, Kristian/Sperling, Karl/Reich, Jens/Rheinberger, Hans-Jörg/Wobus, Anna M./Boysen, Mathias/Domasch, Silke (Hrsg.), Gendiagnostik in Deutschland Status quo und Problemerkundung. Supplement zum Gentechnologiebericht, Bd. 18, Limburg 2007, S. 107–122.

Javitt, Gail H./Hudson, Kathy: Public Health at Risk: Failures in Oversight of Genetic Testing Laboratories (2006), S. 1–22, online verfügbar unter: https://jscholarship.library.jhu.edu/bitstream/handle/1774.2/961/PublicHealthAtRiskFinalWithCover.pdf?sequence=1 (letzter Zugriff: 01.06.2015) (zitiert: Javitt/Hudson, Public Health at Risk).

Javitt, Gail H.: In Search of a Coherent Framework: Options for FDA Oversight of Genetic Tests, Food and Drug Law Journal Vol. 62 (2007), 617–652.

Dies.: Which way for genetic-test regulation? Assign regulation appropriate to the level of risk, Nature Vol. 466 (2010), 817–818.

Dies./Hudson, Kathy: Federal neglect: regulation of genetic testing, Issues in Science and Technol-ogy Vol. 22 (2006), 59–66.

Dies./Katsanis, Sara/Scott, Joan/Hudson, Kathy: Developing the Blueprint for a Genetic Testing Registry, Public Health Genomics Vol. 13 (2010), 95–105.

Dies./Stanley, Erica/Hudson, Kathy: Direct-To-Consumer Genetic Tests, Government Oversight, and the First Amendment: What The Government Can (And Can’t) Do To Protect The Public’s Health, Oklahoma Law Review Vol. 75 (2004), 251–302.

Johnson, Sandra H./Schwartz, Robert L.: Bioethics and law in a nutshell, St. Paul/Minnestoa 2009 (zitiert: Johnson/Schwartz, Bioethics and Law).

Karberg, Sascha: Selbstversuch für Hypochonder?: Das große Geschäft mit dem Gen-Orakel, Handelsblatt Online v. 17.05.2013, online verfügbar unter: http://www.handelsblatt.com/technologie/forschung-medizin/medizin/selbstversuch-fuer-hypochonder-das-grosse-geschaeft-mit-dem-gen-orakel/v_detail_tab_print/8221240.html (letzter Zugriff: 01.06.2015).

Kaye, David H.: GINA’s Genotypes, Michigan Law Review (First Impressions) Vol. 108 (2010), 51–57.

Kim, Pauline T.: Regulating the Use of Genetic Information: Perspectives from the U.S. Experi-ence, Comparative Labor Law & Policy Journal Vol. 31 (2010), 693–705.

King, Jaime S.: Predicting Probability: Regulating the Future of Preimplantation Genetic Screen-ing, Yale Journal of Health Policy, Law, and Ethics Vol. 8 (2008), 283–358.

King, Jamie S.: Duty to the Unborn: A Response to Smolensky, Hastings Law Journal Vol. 60 (2008), 377–396.

Dies./Moulton, Benjamin W.: Rethinking Informed Consent: The Case for Shared Medical Deci-sion-Making, American Journal of Law & Medicine Vol. 32 (2006), 429–501.

Knippers, Rolf: Molekulare Genetik, 9. Auflage, Stuttgart u. a. 2006.Knoppers, Bartha M./Saginur, Madelaine: The Babel of genetic data terminology, Nature Bio-

technology Vol. 23 (2005), 925–927.Kohane, Isaac S./Masys, Daniel R./Altman, Russ B.: The Incidentalome: A Threat to Genomic

Medicine, Journal of the American Medical Association Vol. 296 (2006), 212–215.Kraft, Peter/Hunter, David J.: Genetic Risk Prediction – Are We There Yet?, The New England

Journal of Medicine Vol. 360 (2009), 1701–1703.Kunkel-Razum, Kathrin/Scholze-Stubenrecht, Werner/Wermke, Matthias (Hrsg.), Duden, Deut-

sches Universalwörterbuch. Das umfassende Bedeutungswörterbuch der deutschen Gegen-wartssprache, 7. Auflage, Mannheim, Zürich 2011.

Kutz, Gregory: Direct-To-Consumer Genetic Tests – Misleading Test Results Are Further Com-plicated by Deceptive Marketing and Other Questionable Practices, Statement in: Testimony Before the Subcommittee on Oversight and Investigations, Committee on Energy and Com-merce, House of Representatives, U.S. Government Accountability Office Report 10-847T vom 22.07.2010, S. 1–29, online verfügbar unter: http://www.gao.gov/assets/130/125079.pdf (letzter Zugriff: 01.06.2015).

292 Literatur

Lachance, Christina R./Erby, Lori A. H./Ford, Beth M./Allen, Vincent C./Kaphingst, Kimberly A.: Informational content, literacy demands, and usability of websites offering health-related genetic tests directly to consumers, Genetics in Medicine Vol. 12 (2010), 304–312.

Lanman, Robert B.: An Analysis of the Adequacy of Current Law in Protecting Against Genetic Dis-crimination in Health Insurance and Employment. A Report Commissioned by the Secretary’s Advisory Committee on Genetics, Health, and Society, S. i–23, online verfügbar unter: http://osp.od.nih.gov/sites/default/files/legal_analysis_May2005_0.pdf (letzter Zugriff: 01.06.2015).

Leachman, Sancy A./MacArthur, Daniel G/Angrist, Misha/Gray, Stacey W./Bradbury, Angela R./Vorhaus, Daniel B.: Direct-to-Consumer Genetic Testing: Personalized Medicine in Evolu-tion (Materialien zu einer Präsentation der American Society of Clinical Oncology aus dem Jahr 2011), S. 34–40, online verfügbar unter: http://www.genomicslawreport.com/wp-content/uploads/2011/06/ASCO-DTC-Abstract.pdf (letzter Zugriff: 01.06.2015).

Leighton, J.W/Valverde, K./Bernhardt, B.A.: The General Public’s Understanding and Perception of Direct-to-Consumer Genetic Test Results, Public Health Genomics Vol.15 (2012), 11–21.

Lentzen-Schulte, Martina: Präimplantationsdiagnostik: Junge oder Mädchen?, F.A.Z. vom 02.08.2005, S. 31.

Levy, Samuel/Sutton, Granger/Ng, Pauline C./Feuk, Lars/Halpern, Aaron L./Walenz, Brian P./Axelrod, Nelson/Huang, Jiaqi/Kirkness, Ewen F./Denisov, Gennady/Lin, Yuan/MacDonald, Jeffrey R./Pang, Andy Wing Chun/Shago, Mary/Stockwell, Timothy B./Tsiamouri, Alexia/ Bafna, Vineet/Bansal, Vikas/Kravitz, Saul A./Busam, Dana A./Beeson, Karen Y./McIntosh, Tina C./Remington, Karin A./Abril, Josep F./Gill, John/Borman, Jon/Rogers, Yu-Hui/Frazier, Marvin E./Scherer, Stephen W./Strausberg, Robert L./Venter, J. Craig: The Diploid Genome Sequence of an Individual Human, PLoS Biology Vol. 5 (October 2007), 2113–2144, online verfügbar unter: http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.0050254 (letzter Zugriff: 01.06.2015).

Lewis, M. H./Goldenberg, A./Anderson, R./Rothwell, E./Botkin, J.: State Laws Regarding the Re-tention and Use of Residual Newborn Screening Blood Samples, Pediatrics Vol. 127 (2011), 703–712.

Lin, Zhen/Owen, Art B./Altman, Russ B: Genomic Research and Human Subject Privacy, Science Vol. 305 (2004), 183.

Liu, Yuping/Pearson, Yvette E.: Direct-to-Consumer Marketing of Predictive Medical Genetic Tests: Assessment of Current Practices and Policy Recommendations, Journal of Public Policy & Marketing Vol. 27 (2008), 131–148.

Lo, Y./Chan, K. C./Sun, H./Chen, E./Jiang, P./Lun, F. M./Zheng, Y. W./Leung, T. Y./Lau, T. K./ Cantor, C. R./Chiu, R. W.: Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the Fetus, Science Translational Medicine Vol. 2 (2010), 61ra91, 1–13.

Malinowski, Michael J.: Choosing the Genetic Makeup of Children: Our Eugenics Past-Present, and Future?, Connecticut Law Review Vol. 36 (2003), 125–224.

Ders./Blatt, Robin J. R.: Commercialization of genetic testing services: the FDA, market forces, and biological tarot cards, Tulane Law Review Vol. 71 (1997), 1211–1312.

Mand, Cara/Gillam, Lynn/Delatycki, Martin B./Duncan, Rony E.: Predictive genetic testing in mi-nors for late-onset conditions: a chronological and analytical review of the ethical arguments, Journal of Medical Ethics Vol. 38 (2012), 519–524.

Maxam, Allan M./Gilbert, Walter: A new method for sequencing DNA, Proceedings of the Nation-al Academy of Sciences U.S.A. Vol. 74 (1977), 560–564.

McGuire, Amy/Majumder, Mary Anderlik: Two cheers for GINA?, Genome Medicine Vol. 1 (2009), Artikel 6, 1–3, online verfügbar unter: http://genomemedicine.com/content/pdf/gm6.pdf (letzter Zugriff: 01.06.2015).

Moniodis, Christina P.: Moving from Nixon to NASA: Privacy’s Second Strand – A Right to Infor-mational Privacy, Yale Journal of Law and Technology Vol. 15 (2012), 139–168.

Mouchawar, Judy/Hensley-Alford, Sharon/Laurion, Suzanne/Ellis, Jennifer/Kulchak-Rahm, Alanna/Finucane, Melissa L./Meenan, Richard/Axell, Lisen/Pollack, Rebecca/Ritzwoller,

293Literatur

Debra: Impact of direct-to-consumer advertising for hereditary breast cancer testing on genetic services at a managed care organization: a naturally-occurring experiment, Genetics in Medi-cine Vol. 7 (2005), 191–197.

Müller-Jung, Joachim: Das Massenscreening unserer Genome wird eingefädelt, F.A.Z. vom 07.03.2012, S. N1.

Murray, Thomas H.: Genetic Exceptionalism and “Future Diaries”: Is Genetic Information Differ-ent from Other Medical Information?, in: Rothstein, Mark A. (Hrsg.), Genetic Secrets: Protect-ing Privacy and Confidentiality in the Genetic Era, New Haven/Connecticut 1997, S. 60–73.

Myers, Melanie F.: Health care providers and direct-to-consumer access and advertising of genetic testing in the United States, Genome Medicine Vol. 3 (2011), 1–13, online verfügbar unter: http://genomemedicine.com/content/pdf/gm297.pdf (letzter Zugriff: 01.06.2015).

Nass, Sharyl J./Levit, Laura A./Gostin, Lawrence O.: Beyond the HIPAA Privacy Rule. Enhancing privacy, improving health through research, Washington D.C. 2009.

National Coalition for Health Professional Education in Genetics: Some Health Systems not covered by GINA, online verfügbar unter: http://www.nchpeg.org/index.php?option=com_content&view=article&id=184&tmpl=component (letzter Zugriff: 01.06.2015).

National Conference of State Legislature: Genetics and Health Insurance State Anti-Discrimina-tion Laws (Stand: 2008), online verfügbar unter: http://www.ncsl.org/research/health/genetic-nondiscrimination-in-health-insurance-laws.aspx (letzter Zugriff: 01.06.2015).

Dies.: Genetics and Life, Disability and Long-term Care Insurance (Stand: 2008), online verfügbar unter: http://www.ncsl.org/research/health/genetic-nondiscrimination-laws-in-life-disability.aspx (letzter Zugriff: 01.06.2015).

Dies.: Genetic Employment Laws (Stand: 2008), online verfügbar unter: http://www.ncsl.org/research/health/genetic-employment-laws.aspx (letzter Zugriff: 01.06.2015).

Dies.: Genetic Privacy Laws (Stand: 2008), online verfügbar unter: http://www.ncsl.org/research/health/genetic-privacy-laws.aspx (letzter Zugriff: 01.06.2015).

Dies.: Human Cloning Laws (Stand: 2008), online verfügbar unter: http://www.ncsl.org/research/health/human-cloning-laws.aspx (letzter Zugriff: 01.06.2015).

Nationaler Ethikrat: Prädiktive Gesundheitsinformationen bei Einstellungsuntersuchungen – Stellungnahme (2005), S. 1–69, online verfügbar unter: http://www.ethikrat.org/dateien/pdf/Stellungnahme_PGI_Einstellungsuntersuchungen.pdf (letzter Zugriff: 01.06.2015).

National Human Genome Research Institute: International Consortium Completes Human Ge-nome Project – Pressemitteilung vom 14.04.2003, online verfügbar unter: http://www.genome.gov/pfv.cfm?pageID=11006929 (letzter Zugriff: 01.06.2015).

National Institutes of Health: How Do Other Privacy Protections Interact With the Privacy Rule? (Stand: Februar 2007), online verfügbar unter: http://privacyruleandresearch.nih.gov/pr_05.asp (letzter Zugriff: 01.06.2015).

Dies.: Certificates of Confidentiality (Stand: Januar 2011), online verfügbar unter: http://grants.nih.gov/grants/policy/coc/background.htm (Stand: Januar 2011), (letzter Zugriff: 01.06.2015).

National Newborn Screening and Genetics Resource Center: National Newborn Screening Status Report (Stand: 2012/2013), S. 1–3, online verfügbar unter: http://genes-r-us.uthscsa.edu/sites/genes-r-us/files/nbsdisorders.pdf (letzter Zugriff: 01.06.2015).

New York State Department of Health: Clinical Laboratory Evaluation Program. A Guide to Pro-gram Requirements and Services (Stand: Juni 2014)), S. 1–75, online verfügbar unter: http://www.wadsworth.org/labcert/clep/ProgramGuide/FINAL_JUNE_CLEPPROGRAMGUIDE.pdf (letzter Zugriff: 01.06.2015).

Dass.: Comprehensive Test Approval Policy and Submission Guidelines (Stand: Mai 2013), S. 1–4, online verfügbar unter: http://www.wadsworth.org/labcert/TestApproval/forms/Submission_Guidelines_Policy.pdf (letzter Zugriff: 01.06. 2015).

Nirenberg, Marshall W.: The Genetic Code: II, Scientific American Vol. 208 (1963), 80–95.Norton, Vicki G.: Unnatural selection: nontherapeutic preimplantation genetic screening and pro-

posed regulation, University of California Los Angeles Law Review Vol. 41 (1994), 1581–1650.

Obasogie, Osagie: The Color of Our Genes, Gene Watch Vol. 22 No. 3–4 (2009), 25–27.

294 Literatur

O.V.: Deutsches Human-Genom-Projekt (DHGP), F.A.Z. vom 19.09.2001, online verfügbar unter: http://www.faz.net/aktuell/politik/glossar-gentechnik-deutsches-human-genom-projekt-dhgp-11276684.html (letzter Zugriff: 01.06.2015).

O.V.: Recent Legislation: Health Law – Genetics – Congress Restricts Use of Genetic Information by Insurers and Employers – Genetic Information Nondiscrimination Act of 2008, Harvard Law Review Vol. 122 (2009), 1038–1045.

Offit, Kenneth/Groeger, Elizabeth/Turner, Sam/Wadsworth, Eve A./Weiser, Mary A.: The “Duty to Warn” a Patient’s Family Members About Hereditary Disease Risks, Journal of the American Medical Association Vol. 229 (2004), 1470 (1471).

Palmer, Jennifer: Omaha court case widens from screening test to baby’s meals, Omaha World-Harald vom 13.10.2007, online verfügbar unter: http://www.freerepublic.com/focus/news/1912817/posts (letzter Zugriff. 01.06.2015).

Paltoo, Dina N./Rodriguez, Laura Lyman/Feolo, Michael/Gillanders, Elizabeth/Ramos, Erin M./Rutter, Joni L./Sherry, Stephen/Wang, Vivian Ota/Bailey, Alice/Baker, Rebecca/Caulder, Mark/Harris, Emily L./Langlais, Kristofor/Leeds, Hilary/Luetkemeier, Erin/Paine, Taunton/ Roomian, Tamar/Tryka, Kimberly/Patterson, Amy/Green, Eric D.: Data use under the NIH GWAS Data Sharing Policy and future directions, Nature Genetics Vol. 46 (2014), 934–938.

Patsner, Bruce: New “Home Brew” Predictive Genetic Tests Present Significant Regulatory Prob-lems, Houston Journal of Health Law & Policy Vol. 9 (2009), 237–277.

Pennisi, Elizabeth: DNA Study Forces Rethink of What It Means to Be a Gene, Science Vol. 316 (2007), 1556–1557.

Pinto-Basto, Jorge/Guimarães, Bárbara/Rantanen, Elina/Javaher, Poupak/Nippert, Irma/Cassiman, Jean-Jacques/Kääriäinen, Helena/Kristoffersson, Ulf/Schmidtke, Jörg/Sequeiros, Jorge: Scope of definitions of genetic testing: evidence from a EuroGentest survey, Journal of Community Genetics Vol. 1 (2010), 29–35.

Pirzadeh, Sara/Pritzlaff, Mary: Direct-to-consumer genetic testing and advertising: past, present, and future, Community Oncology Vol. 7 (2010), 315–320.

Pollack, Andrew: Gene Testing Questioned by Regulators, The New York Times vom 26.06.2008, S. C2.

Ders.: Start-Up May Sell Genetic Tests in Stores, The New York Times vom 11.05.2010, S. B2.Ders.: Walgreens Delays Selling Personal Genetic Test Kit, The New York Times vom 13.05.2010,

S. B5.Ders.: F.D.A. Acts on Lab Tests Developed in-House, The New York Times vom 01.08.2014,

S. B1.Pray, Leslie/Robinson, Sally: Challenges for the FDA: The Future of Drug Safety, Washington

D.C. 2007.Preimplantation Genetic Diagnosis International Society: Guidelines for good practice in PGD:

Program requirements and laboratory quality assurance, Reproductive BioMedicine Online, Vol. 16 (2008), 134–147, online verfügbar unter: http://www.rbmojournal.com/article/S1472-6483(10)60567-6/pdf (letzter Zugriff 01.06.2015).

Prince, Anya: State Deceptive Trade Practices and False Advertisement (Stand: Mai 2008), S. 1–11, online verfügbar unter: http://www.law.georgetown.edu/academics/academic-programs/clinical-programs/our-clinics/HIP/upload/Genetic-testing-state-survey-2008.pdf (letzter Zu-griff: 01.06.2015).

Dies.: Comprehensive Protection of Genetic Information: One Size Privacy or Property Models May Not Fit All, Brooklyn Law Review Vol. 79 (2013), 175–227.

Propping, Peter/Aretz, Stefan/Schumacher: Medizinisch-Naturwissenschaftliche Aspekte, in: Propping, Peter/Aretz, Stefan/Schumacher, Johannes/Taupitz, Jochen/Guttmann, Jens/Heinrichs, Bert (Hrsg.), Prädiktive genetische Testverfahren. Naturwissenschaftliche, rechtliche und ethische Aspekte, Bd. 2, Freiburg Breisgau 2006, S. 15–59.

Pschyrembel, Willibald: Klinisches Wörterbuch 2015, 266. Auflage, Berlin, New York 2010.Rabe Smolensky, Kirsten: Creating Children with Disabilities: Parental Tort Liability for Preim-

plantation Genetic Interventions, Hastings Law Journal Vol. 60 (2008), 299–346.

295Literatur

Ram, Natalie: Fortuity And Forensic Familial Identification, Stanford Law Review Vol. 63 (2011), 751–812.

Ray, Turna: With Decode Purchase, Amgen Gains Genetics Expertise, Consumers Lose DTC Testing Option, Pharmacogenomics Reporter vom 12.12.2012, online verfügbar unter: https://www.genomeweb.com/clinical-genomics/decode-purchase-amgen-gains-genetics-expertise-consumers-lose-dtc-testing-option (letzter Zugriff: 01.06.2015).

Rennie, Stuart: The FDA and Helsinki, The Hastings Center Report Vol. 39 (2009), 49.Richards, Edward P.: The Police Power and the Regulation of Medical Practice: A Historical Re-

view and Guide for Medical Licensing Board Regulation of Physicians in ERISA-Qualified Managed Care Organizations, Loyola (Chicago) Annals of Health Law Vol. 8 (1999), 201–237.

Roberts, Jessica L.: Preempting Discrimination: Lessons from the Genetic Information Nondiscrimi-nation Act, Vanderbilt Law Review Vol. 63 (2010), 439–490.

Dies.: The Genetic Information Nondiscrimination Act as an Antidiscrimination Law, Notre Dame Law Review Vol. 68 (2011), 598–648.

Robertson, Andrew S.: Taking Responsibility: Regulations and Protections in Direct-To-Consumer Genetic Testing, Berkeley Technology Law Journal Vol. 24 (2009), 213–243.

Robertson, John A.: Assisting Reproduction, Choosing Genes, and the Scope of Reproductive Freedom, The George Washington Law Review Vol. 76 (2008), 1490–1513.

Robson, Mark E./Storm, Courtney D./Weitzel, Jeffrey/Wollins, Dana S./Offit, Kenneth: American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Can-cer Susceptibility, Journal of Clinical Oncology Vol. 28 (2010), 893–901.

Ropers, H.-Hilger: Wer hat Deutungshoheit über das Genom?, F.A.Z. vom 22.11.2013, S. 7.Rothstein, Mark A.: GINA, the ADA, and Genetic Discrimination in Employment, The Journal of

Law, Medicine & Ethics Vol. 36 (2008), 837–840.Ders.: GINA’s Beauty Is Only Skin Deep, Gene Watch Vol. 22 No. 2 (2009), 9–10, 12.Ders.: Is Deidentification Sufficient to Protect Health Privacy in Research?, The American Journal

of Bioethics Vol. 10 (2010), 3–11.Ders.: Constitutional Right to Informational Health Privacy in Critical Condition, Journal of Law,

Medicine and Ethics Vol. 39 (2011), 280–284.Rubinstein, W. S./Maglott, D. R./Lee, J. M./Kattman, B. L./Malheiro, A. J./Ovetsky, M./Hem, V./

Gorelenkov, V./Song, G./Wallin, C./Husain, N./Chitipiralla, S./Katz, K. S./Hoffman, D./Jang, W./Johnson, M./Karmanov, F./Ukrainchik, A./Denisenko, M./Fomous, C./Hudson, K./Ostell, J. M.: The NIH genetic testing registry: a new, centralized database of genetic tests to en-able access to comprehensive information and improve transparency, Nucleic Acids Research Vol. 41, Database Issue (2013), D925–D935, online verfügbar unter: http://nar.oxfordjournals.org/content/41/D1/D925.full-text-lowres.pdf (letzter Zugriff: 01.06.2015).

Sampson, Kyle/Spector-Bagdady, Kayte: The Regulation of Prescription Drug and Restricted Medical Device Advertising, Engage: The Journal of the Federalist Society’s Practice Groups Vol. 11 (2010), 4–8.

Sanger, Frederick/Coulson, A.R.: A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase, Journal of Molecular Biology Vol. 94 (1975), 441–448.

Sarata, Amanda K./DeBergh, James V./Staman, Jennifer: The Genetic Information Nondiscrimi-nation Act of 2008 and the Patient Protection and Affordable Care Act of 2010: Overview and Legal Analysis of Potential Interactions (21.12.2011), S. 1–12, online verfügbar unter: http://www.genome.gov/Pages/PolicyEthics/GeneticDiscrimination/CRS_GINA_and_ACA.pdf (letzter Zugriff: 01.06.2015) (zitiert: Sarata/DeBergh/Staman, The Genetic Information Nondiscrimination Act of 2008 and the Patient Protection and Affordable Care Act of 2010).

Schiavone, Karen E.: Playing The Odds or Playing God? Limiting Parental Ability to Create Disabled Children Through Preimplantation Genetic Diagnosis, Albany Law Review Vol. 73 (2009), 283–328.

Schlanger, Serra J.: Filling in the Cracks: Improving the Regulation of Direct-To-Consumer Genetic Tests, Journal of Health Care Law and Policy – The Appendix 2011, 1–29.

Dies.: Putting together the pieces: recent proposals to fill in the genetic testing regulatory puzzle, Annals of Health Law Vol. 21 (2012), 383–405.

296 Literatur

Schleckser, Kathryn: Physician Participation in Direct-To-Consumer Genetic Testing: Pragmatism or Paternalism?, Harvard Journal of Law & Technology Vol. 26, 695–730.

Schmidtke, Jörg: Genmedizin im Diagnose-Sektor – Überblick, in: Winter, Stefan F./Fenger, Hermann/Schreiber, Hans-Ludwig (Hrsg.), Genmedizin und Recht. Rahmenbedingungen und Regelungen für Forschung, Entwicklung, Klinik, Verwaltung, München 2001, Rn. 1030–1073.

Ders./Müller-Röber, Bernd/van den Daele, Wolfgang/Hucho, Ferdinand/Köchy, Kristian/Sperling, Karl/Reich, Jens/Rheinberger, Hans-Jörg/Wobus, Anna M./Boysen, Mathias/Domasch, Silke (Hrsg.), Gendiagnostik in Deutschland Status quo und Problemerkundung. Supplement zum Gentechnologiebericht, Bd. 18, Limburg 2007 (zitiert: Bearbeiter, Titel, in: Schmidtke/Müller-Röber/van den Daele u. a. (Hrsg.)).

Schweers, Rachel L.: Newborn Screening Programs: How Do We Best Protect Privacy Rights While Ensuring Optimal Newborn Health, DePaul Law Review Vol. 61 (2012), 869–909.

Secretary’s Advisory Committee on Genetic Testing: Enhancing the Oversight of Genetic Tests: Re-commendations of the SACGT (Juli 2000), S. i–32, online verfügbar unter: http://osp.od.nih.gov/sites/default/files/oversight_report.pdf (letzter Zugriff: 01.06.2015) (zitiert: Secretary’s Advisory Committee on Genetic Testing, Enhancing the Oversight of Genetic Tests (2000)).

Secretary’s Advisory Committee on Genetics, Health, and Society: U.S. System of Oversight of Genetic Testing: A Response to the Charge of the Secretary of Health and Human Services (April 2008). Report of the Secretary’s Advisory Committee on Genetics, Health, and Society, S. i-192 (zzgl. Anhänge A-1–G-6), online verfügbar unter: http://osp.od.nih.gov/sites/default/files/SACGHS_oversight_report.pdf (letzter Zugriff: 01.06.2015) (zitiert: Secretary’s Advisory Committee on Genetics, Health, and Society, Oversight of Genetic Testing (Report 2008)).

Dass.: Direct-to-Consumer Genetic Testing. Report of the Secretary’s Advisory Committee on Genetics, Health and Society (April 2010), S. i–42 (zzgl. Anhänge A-1–B-3), online verfügbar unter: http://osp.od.nih.gov/sites/default/files/SACGHS_DTC_Report_2010.pdf (letzter Zu-griff: 01.06.2015) (zitiert: Secretary’s Advisory Committee on Genetics, Health, and Society, DTC-Genetic Testing (Report 2010)).

Dass.: Genetics Education and Training – Report of the Secretary’s Advisory Committee on Genetics, Health and Society (Februar 2011), S. 1–68 (zzgl. Anhänge A-1–G-21), on-line verfügbar unter: http://www.genome.gov/Pages/Careers/HealthProfessionalEducation/SACGHS-EducationReport2011.pdf (letzter Zugriff: 01.06.2015) (zitiert: Secretary’s Advisory Committee on Genetics, Health, and Society, Genetics Education and Training (Report 2011)).

Shulman, Lee P.: One small step and one giant leap for noninvasive prenatal screening: an edito-rial, American Journal of Obstetrics & Gynecology Vol. 204 (2011), 183–185.

Siedenbiedel, Christian: Meine Gene, meine Zukunft, F.A.Z. vom 19.05.2013, S. 21.Silvers, Anita/Stein, Michael Ashley: An Equality Paradigm for Preventing Genetic Discrimina-

tion, Vanderbilt Law Review Vol. 55 (2002), 1342–1395.Smith, Lloyd M./Sanders, Jane Z./Kaiser, Robert J./Hughes, Peter/Dodd, Chris/Connel, Charles

R/Heiner, Cheryl/Kent, Stephen B.H./Hood, Leroy E.: Fluorescence detection in automated DNA sequence analysis, Nature Vol. 321 (1986), 674–679.

Society for Assisted Reproductive Technology: Use of preimplantation genetic diagnosis for seri-ous adult onset conditions: a committee opinion, Fertility and Sterility Vol. 100 (2013), 54–57.

Soini, Sirpa: Genetic testing legislation in Western Europe – a fluctuating regulatory target, Jour-nal of Community Genetics Vol. 3 (2012), 143–153.

Spork, Peter: Deutschland endlich vorne dran in der Genomforschung, F.A.Z. vom 29.08.2012, S. N1.

Stockter, Ulrich: Das Verbot genetischer Diskriminierung und das Recht auf Achtung der Individualität. Gendiagnostik als Anlass für gleichheits- und persönlichkeitsrechtliche Erwägungen zum Umgang mit prognostischen und anderen statistischen Daten, Berlin 2008 (zitiert: Stockter, Das Verbot genetischer Diskriminierung).

Stollorz, Volker: Meine Gene, deine Gene, F.A.Z. vom 14.02.2011, S. 53.Storm, Courtney/Agarwal, Rinki/Offit, Kenneth: Ethical and Legal Implications of Cancer Genetic

Testing: Do Physicians Have a Duty to Warn Patients’ Relatives About Possible Genetic Risks?, Journal of Oncology Practice Vol. 4 (2008), 229–230.

297Literatur

Suter, Sonia M.: The Allure and Peril of Genetics Exceptionalism: Do We Need Special Genetics Legislation?, Washington University Law Quarterly Vol. 79 (2001), 674–748.

Sutton, Walter S.: On the Morphology of the Chromosome-Group in Brachystola magna, Biology Bulletin Vol. 4 (1902), 24–39.

Tan, Morse Hyun-Myung: Advancing civil rights, the next generation: the GINA of 2008 and be-yond, Health Matrix Vol. 19 (2009), 63–119.

Taupitz, Jochen/Guttmann, Jens: Rechtswissenschaftliche Aspekte, in: Propping, Peter/Aretz, Stefan/Schumacher, Johannes/Taupitz, Jochen/Guttmann, Jens/Heinrichs, Bert (Hrsg.), Prädiktive genetische Testverfahren. Naturwissenschaftliche, rechtliche und ethische Aspekte, Bd. 2, Freiburg Breisgau 2006, S. 59–110.

The President’s Council on Bioethics: Reproduction and Responsibility. The Regulation of New Biotechnologies (März 2004), S. i–252, online verfügbar unter: https://repository.library.georgetown.edu/bitstream/handle/10822/504421/reproduction_responsibility.pdf?sequence=1 (letzter Zugriff: 01.06.2015) (zitiert: The President’s Council on Bioethics, Reproduction and Responsibility (Report 2004)).

The President’s Council on Bioethics: The Changing Moral Focus of Newborn Screening. An Ethical Analysis by the President’s Council on Bioethics (Dezember 2008), S. 1–150, online verfügbar unter: https://repository.library.georgetown.edu/bitstream/handle/10822/548394/newborn_screening.pdf?sequence=1 (letzter Zugriff: 01.06.2015) (zitiert: The President’s Council on Bioethics, Newborn Screening (Report 2008)).

Tuckson, Reed: Secretary’s Advisory Committee on Genetics, Health, and Society Meeting (13./14.11.2006) – Full Committee Discussion, Sitzungsprotokoll, S. 1–25, online verfügbar unter: http://osp.od.nih.gov/sites/default/files/Genetic_Technologies_Discussion.pdf (letzter Zugriff: 01.06.2015).

United Nations: Status of Treaties – Chapter IV Human Rights, 4. International Covenant on Civil and Political Rights, S. 1–83, online verfügbar unter: https://treaties.un.org/doc/Publication/MTDSG/Volume%20I/Chapter%20IV/IV-4.en.pdf (letzter Zugriff: 01.06.2015).

Van Buren, Michael: Closing the Loopholes in the Regulation of Medical Devices: The need for Congress to reevaluate Medical Device Regulation, Health Matrix Vol. 17 (2007), 443–467.

Vasichek, Laurie A.: Genetic Discrimination in the Workplace: Lessons from the Past and Concerns for the Future, Saint Louis University Journal of Health Law & Policy Vol. 3 (2009), 13–40.

Venter, J. Craig: The Sequence of the Human Genome, Science Vol. 291 (2001), 1304–1351.Ders.: Multiple personal genomes await, Nature Vol. 464 (2010), 676–677.Ders.: The Human Genome at 10: Successes and Challenges, Science Vol. 331 (2011), 546–547.VerBruggen, Robert: The FDA’s Genetic Paternalism, National Review Online vom 23.03.2011, on-

line verfügbar unter: http://www.nationalreview.com/article/262752/fdas-genetic-paternalism-robert-verbruggen (letzter Zugriff: 01.06.2015).

Wagner, Jennifer K.: Long-Awaited Announcement from the FDA on LDTs, Genomics Law Re-port vom 01.08.2014, online verfügbar unter: http://www.genomicslawreport.com/index.php/author/wagjen/ (letzter Zugriff: 01.06.2015).

Wagner, Lynn: A Test Before Its Time? FDA Stalls Distribution Process of Proteomic Test, Journal of the National Cancer Institute Vol. 96 (2004), 500–501.

Washington Legal Foundation: Citizen Petition Regarding FDA Regulation of Laboratory De-veloped Tests vom 28.09.2006, S. 1–19, online verfügbar unter: http://www.wlf.org/upload/Clinical%20Labs-%20FDA%20Citizen%20Petition.pdf (letzter Zugriff: 01.06.2015)

Watson, James D./Crick, Francis H.C.: Molecular Structure of Nucleic Acids. A Structure for Deoxyribose Nucleic Acid, Nature Vol. 171 (1953), 737–738.

Weiss, Ronald L.: The Long and Winding Regulatory Road for Laboratory-Developed Tests, American Journal of Clinical Pathology Vol. 138 (2012), 20–26.

Wevers, Kate: Prenatal Torts and Pre-Implantation Genetic Diagnosis, Harvard Journal of Law & Technology Vol. 24 (2010), 257–280.

Wiese, Günther: Zu einer gesetzlichen Regelung genetischer Untersuchungen im Arbeitsleben, Betriebs-Berater 2005, 2073–2083.

298 Literatur

Williams, Benjamin B.: Screening for Children: Choice and Chance in the “Wild West” of Repro-ductive Medicine, The George Washington Law Review Vol. 79 (2011), 1305–1342.

Williams, Erin D.: Federal Protection for Human Research Subjects: An Analysis of the Common Rule and Its Interactions with FDA Regulations and the HIPAA Privacy Rule, Congressional Research Service Report for Congress (Juni 2005), S. 1–76, online verfügbar unter: http://www.fas.org/sgp/crs/misc/RL32909.pdf (letzter Zugriff: 01.06.2015) (zitiert: Williams, Analy-sis of the Common Rule and Its Interactions with FDA Regulations and the HIPAA Privacy Rule).

Williams, Marc: Déjà Vu All Over Again?, Gene Watch Vol. 25 No. 4 (2012), 13–15.Williams-Jones, Bryn: „Be ready against cancer, now“: direct-to-consumer advertising for genetic

testing, New Genetics and Society Vol. 25 (2006), 89–107.Winter, Stefan F.: Einführung, in: Winter, Stefan F./Fenger, Hermann/Schreiber, Hans-Ludwig

(Hrsg.), Genmedizin und Recht. Rahmenbedingungen und Regelungen für Forschung, Ent-wicklung, Klinik, Verwaltung, München 2001, Rn. 1–115.

Wolf, Susan M./Annas, George J./Elias, Sherman: Patient Autonomy and Incidental Findings in Clinical Genomics, Science Vol. 340 (2013), 1049–1050.

Wolinsky, Howard: The battle of Helsinki, European Molecular Biology Organization Reports Vol. 7 (2006), 670–672.

World Health Organization: Proposed International Guidelines on Ethical Issues in Medical Genet-ics and Genetic Services. Report on a WHO Meeting (December 15th/16th 1997) on Ethi-cal Issues in Medical Genetics (1998), S. 1–24, online verfügbar unter: http://www.who.int/genomics/publications/en/ethicalguidelines1998.pdf (letzter Zugriff: 01.06.2015) (zitiert: World Health Organization, Proposed International Guidelines on Ethical Issues in Medical Genetics and Genetic Services (Report 1998)).

Yost, Judy/Mattingly, Penny: CLIA and Equivalent Quality Control: Options For The Future, La-boratory Medicine Vol. 36 (2005), 614–616.

Ziegler, Julian: Genanalysen in der deutschen privaten Krankenversicherung, Frankfurt am Main u. a. 2008 (zitiert: Ziegler, Genanalysen).